Isolation and characterization of clostridium difficile toxin-specific single-domain antibodies

Methods in Molecular Biology

Volumn 911, Issue , 2012, Pages 211-239

  Hussack, Greg ^a,b   Arbabi Ghahroudi, Mehdi ^a,c,d   MacKenzie, C Roger ^a,c   Tanha, Jamshid ^a,b,c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d CARLETON UNIVERSITY   (Canada)

Author keywords

Clostridium difficile; Immunotherapy; Infectious disease; Single domain antibody; Toxin; VHH

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; EPITOPE; NANOBODY; RECOMBINANT ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CAMEL; CLOSTRIDIUM DIFFICILE; COMPLEMENTARITY DETERMINING REGION; HUMAN; IMMUNIZATION; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL;

EID: 84934440453     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-968-6_14     Document Type: Article

References (31)

1. Wesolowski J et al (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol 198:157-174
2. Stewart CS, MacKenzie CR, Hall JC (2007) Isolation, characterization and pentamerization of alpha-cobrotoxin speci fic single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development. Toxicon 49:699-709
3. Stone E et al (2007) A novel pentamer versus pentamer approach to generating neutralizers of verotoxin 1. Mol Immunol 44:2487-2491
4. Hmila I et al (2008) VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing ef ficacy for scorpion toxin AahI ¢. Mol Immunol 45:3847-3856
5. Hmila I et al (2010) A bispecific nanobody to provide full protection against lethal scorpion envenoming. FASEB J 24:3479-3489
6. Goldman ER et al (2008) Thermostable llama single domain antibodies for detection of botu-linum A neurotoxin complex. Anal Chem 80:8583-8591
7. Conway JO et al (2010) Llama single domain antibodies speci fic for the 7 botulinum neuro-toxin serotypes as heptaplex immunoreagents. PLoS One 5:e8818
8. Dong J et al (2010) A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region. J Mol Biol 397:1106-1118
9. Goldman ER et al (2006) Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem 78:8245-8255
10. Adams H et al (2009) Speci fic immuno capturing of the staphylococcal superantigen toxin-shock syndrome toxin-1 in plasma. Biotechnol Bioeng 104:143-151
11. Harmsen MM, van Solt CB, Fijten HP (2009) Enhancement of toxin-and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation. Appl Microbiol Biotechnol 84:1087-1094
12. Koch-Nolte F et al (2007) Single domain antibodies from llama effectively and speci fically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo. FASEB J 21:3490-3498
13. Alzogaray V et al (2010) Single-domain llama antibodies as speci fic intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium. FASEB J 25:526-534
14. Anderson GP et al (2007) Multiplexed fluid array screening of phage displayed anti-ricin single domain antibodies for rapid assessment of specificity. Biotechniques 43: 806-811
15. Hussack G et al (2011) Neutralization of Clostridium dif ficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem 286:8961-8976.
16. Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium dif ficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526-536
17. Lowy I et al (2010) Treatment with monoclonal antibodies against Clostridium dif ficile toxins. N Engl J Med 362:197-205
18. Hussack G, Tanha J (2010) Toxin-speci fic antibodies for the treatment of Clostridium dif ficile: current status and future perspectives. Toxins 2:998-1018
19. Demarest SJ et al (2010) Neutralization of Clostridium dif ficile toxin A using antibody combinations. MAbs 2:1-9
20. H phage-display libraries. Methods Mol Biol 525:187-216
21. Nguyen VK, Desmyter A, Muyldermans S (2001) Functional heavy-chain antibodies in Camelidae. Adv Immunol 79:261-296
22. Doyle PJ et al (2008) Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxyniva-lenol. Mol Immunol 45:3703-3713
23. De Simone E et al (2006) Immunochemical analysis of IgG subclasses and IgM in South American camelids. Small Ruminant Res 64:2-9
24. Sambrook J, Fritsch EF, Maniatis T (eds) (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
25. Tung WL, Chow KC (1995) A modi fied medium for ef ficient electrotransformation of E. coli. Trends Genet 11:128-129
26. Muyldermans S, Cambillau C, Wyns L (2001) Recognition of antigens by single-domain antibody fragments: the super fluous luxury of paired domains. Trends Biochem Sci 26: 230-235
27. Harmsen MM et al (2000) Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol Immunol 37:579-590
28. Keel MK, Songer JG (2007) The distribution and density of Clostridium dif ficile toxin receptors on the intestinal mucosa of neonatal pigs. Vet Pathol 44:814-822
29. Arbabi Ghahroudi M et al (1997) Selection and identi fication of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414:521-526
30. Kabat EA et al (eds) (1991) Sequences of proteins of immunological interest. US Department of Health and Human Services, US Public Health Service, Bethesda, MD
31. Salnikova MS et al (2008) Physical characterization of Clostridium difficile toxins and tox-oids: effect of the formaldehyde crosslinking on thermal stability. J Pharm Sci 97:3735-3752